Mapping Novel Disease Genes for Dilated Cardiomyopathy
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To identify new dilated cardiomyopathy genes by genetic linkage and mutational analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2002
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 30, 2002
CompletedFirst Posted
Study publicly available on registry
October 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedFebruary 20, 2014
February 1, 2014
3.9 years
September 30, 2002
February 19, 2014
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Mayo Cliniclead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Related Publications (1)
Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA. 2005 Jan 26;293(4):447-54. doi: 10.1001/jama.293.4.447.
PMID: 15671429BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
Timothy Olson
Mayo Clinic
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 30, 2002
First Posted
October 1, 2002
Study Start
July 1, 2002
Primary Completion
June 1, 2006
Study Completion
June 1, 2006
Last Updated
February 20, 2014
Record last verified: 2014-02